The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist.
Abegg AL, Vickery LE, Bremer ME, Donnelly AM, Doshi PD, Evans ML, Thurman TL, Braford SR, Caparon MH, Bauer SC, Giri JG, Welply JK, McKearn JP, Smith WG.
Abegg AL, et al. Among authors: mckearn jp.
Leukemia. 2002 Mar;16(3):316-26. doi: 10.1038/sj.leu.2402366.
Leukemia. 2002.
PMID: 11896534